| 12384778 |
Pyrazolopyridine compounds and uses thereof |
Oleg Vechorkin, Kai Liu, Alexander Sokolsky, Anlai Wang, Hai Fen Ye +2 more |
2025-08-12 |
|
| 12187725 |
Tricyclic urea compounds as JAK2 V617F inhibitors |
Yanran Ai, Yu Sheng Bai, Joseph Barbosa, Hao Feng, Leah C. Konkol +5 more |
2025-01-07 |
|
| 12030889 |
Imidazopyridazine and imidazopyridine compounds and uses thereof |
Jeremy Roach, Song Mei, Chunhong He, Liangxing Wu, Wenqing Yao |
2024-07-09 |
$15,981,000 |
| 11891388 |
Pyrazolopyridine compounds and uses thereof |
Kai Liu, Alexander Sokolsky, Oleg Vechorkin, Hai Fen Ye, Qinda Ye +1 more |
2024-02-06 |
$73,659,000 |
| 11840546 |
Imidazopyridazine compounds and uses thereof |
Yu Sheng Bai, Liangxing Wu, Wenqing Yao |
2023-12-12 |
$44,258,000 |
| 11795166 |
Pyrazolopyridine compounds and uses thereof |
Oleg Vechorkin, Kai Liu, Alexander Sokolsky, Anlai Wang, Hai Fen Ye +1 more |
2023-10-24 |
$72,022,000 |
| 11780840 |
Tricyclic urea compounds as JAK2 V617F inhibitors |
Yanran Ai, Onur Atasoylu, Yu Sheng Bai, Joseph Barbosa, David M. Burns +11 more |
2023-10-10 |
$36,712,000 |
| 11767323 |
Tricyclic pyridone compounds as JAK2 V617F inhibitors |
Kai Liu, Onur Atasoylu, Yu Sheng Bai, Andrew W. Buesking, Leah C. Konkol +4 more |
2023-09-26 |
$37,874,000 |
| 11731958 |
Carboxamide compounds and uses thereof |
Oleg Vechorkin, Alexander Sokolsky, Evan Styduhar, Wenqing Yao |
2023-08-22 |
$81,224,000 |
| 11542265 |
Pyrazolopyrimidine compounds and uses thereof |
Oleg Vechorkin, Kai Liu, Alexander Sokolsky, Hai Fen Ye, Qinda Ye +2 more |
2023-01-03 |
$109,658,000 |
| 11459329 |
Imidazopyridazine and imidazopyridine compounds and uses thereof |
Jeremy Roach, Song Mei, Chunhong He, Liangxing Wu, Wenqing Yao |
2022-10-04 |
$97,479,000 |
| 11406624 |
Pyrazolopyridine compounds and uses thereof |
Alexander Sokolsky, Oleg Vechorkin, Kai Liu, Wenqing Yao, Qinda Ye |
2022-08-09 |
$27,181,000 |
| 11242343 |
Pyrazolopyridine compounds and uses thereof |
Kai Liu, Alexander Sokolsky, Oleg Vechorkin, Hai Fen Ye, Qinda Ye +1 more |
2022-02-08 |
$44,540,000 |
| 11229631 |
Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitors |
Chu-Biao Xue, Yun-Long Li, Hao Feng, Anlai Wang, Ke Zhang +3 more |
2022-01-25 |
$105,895,000 |
| 11136326 |
Pyrrolopyrimidine derivatives as TAM inhibitors |
Yun-Long Li, David M. Burns, Hao Feng, Joseph Glenn, Chunhong He +3 more |
2021-10-05 |
$99,349,000 |
| 11014929 |
Pyrazolopyrimidine compounds and uses thereof |
Oleg Vechorkin, Kai Liu, Alexander Sokolsky, Hai Fen Ye, Qinda Ye +2 more |
2021-05-25 |
$72,363,000 |
| 10800761 |
Carboxamide compounds and uses thereof |
Oleg Vechorkin, Alexander Sokolsky, Evan Styduhar, Wenqing Yao |
2020-10-13 |
$41,718,000 |
| 10723705 |
Heterocyclic compounds and uses thereof |
Xiaozhao Wang, Joseph Barbosa, Wenqing Yao, Yingda Ye |
2020-07-28 |
$60,820,000 |
| 10519163 |
Pyrrolopyrimidine derivatives as TAM inhibitors |
Yun-Long Li, David M. Burns, Hao Feng, Joseph Glenn, Chunhong He +3 more |
2019-12-31 |
$124,812,000 |
| 10280164 |
Pyrazolopyridone compounds and uses thereof |
Qinda Ye, Kai Liu, Alexander Sokolsky, Oleg Vechorkin, Wenqing Yao |
2019-05-07 |
$62,913,000 |
| 10266530 |
Pyrazolopyridine compounds and uses thereof |
Oleg Vechorkin, Kai Liu, Alexander Sokolsky, Anlai Wang, Hai Fen Ye +1 more |
2019-04-23 |
$56,428,000 |
| 10053465 |
Pyrrolopyrimidine derivatives as TAM inhibitors |
Yun-Long Li, David M. Burns, Hao Feng, Joseph Glenn, Chunhong He +4 more |
2018-08-21 |
$131,747,000 |
| 10000507 |
Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors |
Yun-Long Li, David M. Burns, Hao Feng, Taisheng Huang, Song Mei +5 more |
2018-06-19 |
$144,867,000 |
| 9890162 |
Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors |
Yaping Sun, Hao Feng, Yun-Long Li, Song Mei, Anlai Wang +2 more |
2018-02-13 |
$75,759,000 |
| 9676750 |
Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors |
Yun-Long Li, David M. Burns, Hao Feng, Chu-Biao Xue, Anlai Wang |
2017-06-13 |
$228,650,000 |